Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR - Cehajic-Kapetanovic, J; Xue, K; Martinez-Fernandez de la Camara, C; Nanda, A; Davies, A; Wood, LJ; Salvetti, AP; Fischer, MD; Aylward, JW; Barnard, AR; Jolly, JK; Luo, E; et al. (Nature Medicine, 2020)